Former NFL pro Chris Maragos wins $43.5 million medical malpractice claim

Published Date: 02 Mar 2023

The legal team said the jury's decision could make medics think twice before allowing the injured to return to the field.

Read Full News

Latest News

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Episode 3: Cracking the Code: Insulin Resistance in HS

What if your HS patient's normal labs are hiding a metabolic storm? Drs Okoye and Bordone explore overlooked clues, HOMA-IR, and real-world GLP-1 outcomes.

Medicaid Status May Worsen Complications After Heart Transplantation

Medicaid Status May Worsen Complications After Heart Transplantation

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

Aesthetician Charged With Injecting Customers With Counterfeit Botox

Some clients faced life-threatening injuries after receiving injections, said federal authorities

What to Know About President Trump's Order Targeting Transgender Rights

A closer look at the executive order

Todays Updates

Rheumatology in 2025: Year in Review Victoria Johnson

The rheumatology year in review highlights FDA approvals and pivotal data readouts.

Nipocalimab Reduces SLE Disease Activity, Meeting JASMINE Study End Point Victoria Johnson

Johnson & Johnson plans to initiate a phase 3 study based off the positive data.

Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1 Louie Pasculli

Treatment with the orexin-receptor 2 agonist oveporexton was associated with improvements in attention, memory, and executive function in adults with narcolepsy type 1.

Phase 3 Data Readout of EMPEROR Study to Come Earlier, With FDA Submission Expected to Follow Marco Meglio

Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.

sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis Marco Meglio

The FDA is expected to have a decision on efgartigimod as potentially the first approved therapy for seronegative myasthenia gravis by May 10, 2026.

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Todays Updates

Rheumatology in 2025: Year in Review Victoria Johnson

The rheumatology year in review highlights FDA approvals and pivotal data readouts.

Nipocalimab Reduces SLE Disease Activity, Meeting JASMINE Study End Point Victoria Johnson

Johnson & Johnson plans to initiate a phase 3 study based off the positive data.

Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1 Louie Pasculli

Treatment with the orexin-receptor 2 agonist oveporexton was associated with improvements in attention, memory, and executive function in adults with narcolepsy type 1.

Phase 3 Data Readout of EMPEROR Study to Come Earlier, With FDA Submission Expected to Follow Marco Meglio

Those from the clinical community may expect to hear data from the registrational trial assessing zorevunersen in Dravet syndrome by mid-2027.

sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis Marco Meglio

The FDA is expected to have a decision on efgartigimod as potentially the first approved therapy for seronegative myasthenia gravis by May 10, 2026.

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Latest News

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

What if your HS patient's normal labs are hiding a metabolic storm? Drs Okoye and Bordone explore overlooked clues, HOMA-IR, and real-world GLP-1 outcomes.

Medicaid Status May Worsen Complications After Heart Transplantation

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

Some clients faced life-threatening injuries after receiving injections, said federal authorities

A closer look at the executive order

News All Time

New Guideline Revises Cautions Around Dental Work in Joint Replacement Patients

Surgeons' groups acknowledge that prophylactic antibiotics may not cut infection risk

How 'General Hospital' Missed a Chance to Promote Living Organ Donation

A recent storyline offered a negative spin

Half-Truths, Big Risks: The Dangers of an Incomplete Medical History

Creating an environment that fosters open communication is essential

Anthem Blue Cross Blue Shield Reverses Decision to Put a Time Limit on Anesthesia

Change comes after widespread outcry

Inside the OR: Cervical Artificial Disc Replacement

Watch orthopedic spinal surgeon Antonio Webb, MD, perform this complex procedure

Trump's FDA Pick Is MedPage Today's Former Top Editor

Marty Makary has made a name for himself challenging the medical establishment

How Impactful is EMPACT-MI on Heart Failure: EMPACT-MI Trial

The trial evaluated the efficacy of empagliflozin to reduce cardiovascular risk in patients after acute myocardial infarction.

Nationwide IV Fluid Shortage Could Change How Hospitals Manage Patient Hydration

Crisis expected to last a long time, according to one expert

One-day Decompression at Allegheny Health Network

One-day Decompression at Allegheny Health Network

Alarming Surge in Alcohol-Related Liver Transplants in Younger Adults

Targeted preventive strategies needed, especially for younger women, researchers say

Health Worker Gets 2 Years for Accessing Ruth Bader Ginsburg's Medical Records

Transplant coordinator was convicted earlier this year

The Robot Will See You Now

Robotics may not be the answer for primary care right now, but "smart systems" sure could help

Resistance Training Falls Short in Severe Hip Arthritis

Trial finds conservative approach inferior to joint replacement

People Opting Out of Organ Donation After Donor Mistakenly Declared Dead

The alleged incident even affected donations in France

I'm a Black Trauma Surgeon. Ending Gun Violence Demands Fighting for Racial Justice.

An excerpt from Williams' book, The Bodies Keep Coming

UVA Health Surgeons Sound Alarm on Upcoding

Leaked meeting audio latest development in ongoing strife at health system, medical school

Recommended News For You

Small Renal Mass Surveillance Does Not Affect Nephron-Sparing Surgery.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

'Ray of hope': New developments in the fight against various cancers.

MRI can save rectal cancer patients from surgery, study suggests

Immunotherapy after surgery is good for patients with advanced cancer

What is Mohs micrographic surgery? 8 FAQs about Mohs

Francis Collins reveals that he was diagnosed with "aggressive" prostate cancer.

Recommended Articles For You

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options  

Clinical Analysis of Prostate Cancer 

Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care 

Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.

2.

PFS in R/R Mantle Cell Lymphoma is Improved by Ibrutinib-Venetoclax.

3.

Nasal therapeutic HPV vaccine could prevent cervical cancer

4.

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

5.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

1.

Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment

2.

The Growing Crisis of Aplastic Anemia: A Call for Action

3.

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy

4.

Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment

5.

Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

2.

Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

4.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

5.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot